Michel Daudon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Michel Daudon has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Paul Jungers
Necker-Enfants Malades Hospital, APHP
4 shared publications Fabrice Cohen-Solal
Laboratoire de Biochimie A, Hôpital Necker, 149, Rue de Sèvres, 75743 Paris 15, AP-HP, Paris, France
2 shared publicationsA. Cosnefroy
Danone Research, RD128, 91767 Palaiseau Cedex, France
1 shared publicationBernard Lacour
Laboratoire de Biochimie A, Hôpital Necker, 149, Rue de Sèvres, 75743 Paris Cedex 15, AP-HP, Paris, France (F.C.-S., B.D., B.L., M.D.); and Bruker Optique, Wissembourg, France (J.C.B.)
1 shared publicationBéatrice Dabrowsky
Laboratoire de Biochimie A, Hôpital Necker, 149, Rue de Sèvres, 75743 Paris Cedex 15, AP-HP, Paris, France (F.C.-S., B.D., B.L., M.D.); and Bruker Optique, Wissembourg, France (J.C.B.)
1 shared publicationClaire Hubert
1 shared publication
Latest Publications
- 1 October 2015
- Published by Oxford University Press (OUP)
- p. 1661-1665
Uric acid stones
- 1 October 2015
- Published by Oxford University Press (OUP)
- p. 1666-1670
Cystine stones
- 1 September 2015
- Published by Elsevier in Progrès en Urologie
- Vol. 25 (10) , 590-597
Infections des voies urinaires : impact économique de la consommation d’eau
- 1 September 2015
- Published by Elsevier in Progrès en Urologie
- Vol. 25 (10) , 590-597
Infections des voies urinaires : impact économique de la consommation d’eau
- 1 March 2011
- Vol. 83 (1) , 43-50
Increasing water intake by 2 liters reduces crystallization risk indexes in healthy subjects.
The objective of the present study was to evaluate the effects of drinking 2 additional litres of water/day on several urinary risk factors for lithiasis in healthy subjects, through measurement of crystallization risk indices (Tiselius CRI). 48 healthy subjects, aged 25 to 50 were studied for urinary parameters including CRI in the laboratory ward, for 24 hours. After this first period, they were randomized either to a 2L/d additional water intake (treated group) or usual fluid consumption (control group) for a 6 days period, which ended by a second measurement period in the laboratory ward for 24 hours. Total additional water intake was actually 1.3L/d on average in treated subjects, because subjects decreased other usual sources of fluid intake. In 24 hour urine, Tiselius CRI varied differently among treated subjects and controls between the 2 periods; male controls subjects experienced much higher values (above 2 in average in first morning urine sample) in the second period (p = 0.05). Of interest, in a transversal analysis, we observed a positive relation between BMI or waist circumference on the one hand, and with 24 hour urea excretion or osmotic load on the other hand. These results show a beneficial effect of a final 1.3L additional water intake on Tiselius CRI in healthy subjects.
- 1 March 2011
- Vol. 83 (1) , 43-50
Increasing water intake by 2 liters reduces crystallization risk indexes in healthy subjects.
The objective of the present study was to evaluate the effects of drinking 2 additional litres of water/day on several urinary risk factors for lithiasis in healthy subjects, through measurement of crystallization risk indices (Tiselius CRI). 48 healthy subjects, aged 25 to 50 were studied for urinary parameters including CRI in the laboratory ward, for 24 hours. After this first period, they were randomized either to a 2L/d additional water intake (treated group) or usual fluid consumption (control group) for a 6 days period, which ended by a second measurement period in the laboratory ward for 24 hours. Total additional water intake was actually 1.3L/d on average in treated subjects, because subjects decreased other usual sources of fluid intake. In 24 hour urine, Tiselius CRI varied differently among treated subjects and controls between the 2 periods; male controls subjects experienced much higher values (above 2 in average in first morning urine sample) in the second period (p = 0.05). Of interest, in a transversal analysis, we observed a positive relation between BMI or waist circumference on the one hand, and with 24 hour urea excretion or osmotic load on the other hand. These results show a beneficial effect of a final 1.3L additional water intake on Tiselius CRI in healthy subjects.
- 1 November 2004
- Vol. 44 (5) , 799-805
ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention.
The contribution of nephrolithiasis-related end-stage renal disease (ESRD) to patients requiring renal replacement therapy has never been specifically evaluated. Of the entire cohort of 1,391 consecutive patients who started maintenance dialysis therapy at our nephrology department between January 1989 and December 2000, a total of 45 patients (21 men) had renal stone disease as the cause of ESRD and constitute the study material. Type and cause of renal stone disease was determined in the 45 patients, as well as the change in prevalence of nephrolithiasis-related ESRD with time during this 12-year period. The overall proportion of nephrolithiasis-related ESRD was 3.2%. Infection (struvite) stones accounted for 42.2%; calcium stones, 26.7%; uric acid nephrolithiasis, 17.8%; and hereditary diseases (including primary hyperoxaluria type 1 and cystinuria), 13.3% of cases. Women were predominant among patients with infection and calcium stones, whereas men were predominant among patients with uric acid or hereditary stone disease. The proportion of patients with nephrolithiasis-related ESRD decreased from 4.7% in the triennial period 1989 to 1991 to 2.2% in the most recent period, 1998 to 2000 ( P = 0.07). This tendency to a decreasing prevalence mainly was caused by a rarefaction of infection and calcium stones with time, whereas frequencies of uric acid and hereditary stone disease remained essentially unchanged. Severe forms of nephrolithiasis remain an underestimated cause of potentially avoidable ESRD and need for renal replacement therapy. These findings highlight the crucial importance of accurate stone analysis and metabolic evaluation to provide early diagnosis and proper therapy for conditions that may lead to ESRD through recurrent stone formation and/or parenchymal crystal infiltration.
- 1 November 2004
- Vol. 44 (5) , 799-805
ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention.
The contribution of nephrolithiasis-related end-stage renal disease (ESRD) to patients requiring renal replacement therapy has never been specifically evaluated. Of the entire cohort of 1,391 consecutive patients who started maintenance dialysis therapy at our nephrology department between January 1989 and December 2000, a total of 45 patients (21 men) had renal stone disease as the cause of ESRD and constitute the study material. Type and cause of renal stone disease was determined in the 45 patients, as well as the change in prevalence of nephrolithiasis-related ESRD with time during this 12-year period. The overall proportion of nephrolithiasis-related ESRD was 3.2%. Infection (struvite) stones accounted for 42.2%; calcium stones, 26.7%; uric acid nephrolithiasis, 17.8%; and hereditary diseases (including primary hyperoxaluria type 1 and cystinuria), 13.3% of cases. Women were predominant among patients with infection and calcium stones, whereas men were predominant among patients with uric acid or hereditary stone disease. The proportion of patients with nephrolithiasis-related ESRD decreased from 4.7% in the triennial period 1989 to 1991 to 2.2% in the most recent period, 1998 to 2000 ( P = 0.07). This tendency to a decreasing prevalence mainly was caused by a rarefaction of infection and calcium stones with time, whereas frequencies of uric acid and hereditary stone disease remained essentially unchanged. Severe forms of nephrolithiasis remain an underestimated cause of potentially avoidable ESRD and need for renal replacement therapy. These findings highlight the crucial importance of accurate stone analysis and metabolic evaluation to provide early diagnosis and proper therapy for conditions that may lead to ESRD through recurrent stone formation and/or parenchymal crystal infiltration.
- 1 June 2004
- Published by SAGE Publications in Applied Spectroscopy
- Vol. 58 (6) , 671-678
Automated Fourier Transform Infrared Analysis of Urinary Stones: Technical Aspects and Example of Procedures Applied to Carbapatite/Weddellite Mixtures
New software (ScanLith) was developed to provide an automated procedure for identifying and quantifying crystalline species in urinary calculi. The first step was to strictly define operative conditions of sample preparation because they have a significant influence on the stability of various crystalline phases. Second, we determined the quantification coefficients of a polynomial curve required to develop the automated procedure. This was illustrated by the study of carbapatite and weddellite, as both constituents represent one of the most frequent associations found in stones analyzed in our laboratory. The following quadratic equation was obtained with a correlation coefficient r 2 = 0.9997: Y = −0.5144 x 2 + 1.5239 x – 0.0141, where Y is the absorbance ratio carbapatite/weddellite and x is the percentage of carbapatite in the mixture. The absorbance of carbapatite and weddellite was measured at 1035 cm −1 and 1325 cm −1 , respectively. The third step was to validate the ScanLith procedure in routine analysis by comparing computed results with those of an expert. Concordance ( r 2 = 0.9824) was better than that previously reported using various computerized systems with a mean deviation of 4%. Algorithms developed in ScanLith to identify main and minor components found in urinary stones, even in complex mixtures containing up to seven constituents, allowed us to lower the detection threshold down to 1 to 10% depending on the main component.
- 1 June 2004
- Published by SAGE Publications in Applied Spectroscopy
- Vol. 58 (6) , 671-678
Automated Fourier Transform Infrared Analysis of Urinary Stones: Technical Aspects and Example of Procedures Applied to Carbapatite/Weddellite Mixtures
New software (ScanLith) was developed to provide an automated procedure for identifying and quantifying crystalline species in urinary calculi. The first step was to strictly define operative conditions of sample preparation because they have a significant influence on the stability of various crystalline phases. Second, we determined the quantification coefficients of a polynomial curve required to develop the automated procedure. This was illustrated by the study of carbapatite and weddellite, as both constituents represent one of the most frequent associations found in stones analyzed in our laboratory. The following quadratic equation was obtained with a correlation coefficient r 2 = 0.9997: Y = −0.5144 x 2 + 1.5239 x – 0.0141, where Y is the absorbance ratio carbapatite/weddellite and x is the percentage of carbapatite in the mixture. The absorbance of carbapatite and weddellite was measured at 1035 cm −1 and 1325 cm −1 , respectively. The third step was to validate the ScanLith procedure in routine analysis by comparing computed results with those of an expert. Concordance ( r 2 = 0.9824) was better than that previously reported using various computerized systems with a mean deviation of 4%. Algorithms developed in ScanLith to identify main and minor components found in urinary stones, even in complex mixtures containing up to seven constituents, allowed us to lower the detection threshold down to 1 to 10% depending on the main component.
- 1 January 2004
- Published by Springer Nature in Drugs
- Vol. 64 (3) , 245-275
Drug-Induced Renal Calculi
Drug-induced calculi represent 1–2% of all renal calculi. The drugs reported to produce calculi formation may be divided into two groups. The first one includes poorly soluble drugs with high urine excretion that favours crystallisation in the urine. Among poorly soluble molecules, triamterene was the leading cause of drug-containing urinary calculi in the 1970s, and it is still currently responsible for a significant number of calculi. In the last decade, drugs used for the treatment of HIV-infected patients, namely indinavir and sulfadiazine, have become the most frequent cause of drug-containing urinary calculi. Besides these drugs, about twenty other molecules may induce nephrolithiasis in patients receiving long-term treatment or high doses. Calculi analysis by physical methods, including infrared spectroscopy or x-ray diffraction, is needed to demonstrate the presence of the drug or its metabolites within the calculi. The second group includes drugs that provoke urinary calculi as a consequence of their metabolic effects. Here, diagnosis relies on careful clinical inquiry because physical methods are ineffective to differentiate between urinary calculi induced by the metabolic effects of a drug and common metabolic calculi. The incidence of such calculi, especially those resulting from calcium/vitamin D supplementation, is probably underestimated. Although drug-induced urinary calculi most often complicate high-dose, long-duration drug treatments, there also exist specific patient risk factors in relation to urine pH, urine output and other parameters, which provide a basis for preventive or curative treatment of calculi. Better awareness of the possible occurrence of lithogenic complications, preventive measures based on drug solubility characteristics and close surveillance of patients on long-term treatment with drugs with lithogenic potential, especially those with a history of urolithiasis, should reduce the incidence of drug-induced nephrolithiasis.
- 1 January 2004
- Published by Springer Nature in Drugs
- Vol. 64 (3) , 245-275
Drug-Induced Renal Calculi
Drug-induced calculi represent 1–2% of all renal calculi. The drugs reported to produce calculi formation may be divided into two groups. The first one includes poorly soluble drugs with high urine excretion that favours crystallisation in the urine. Among poorly soluble molecules, triamterene was the leading cause of drug-containing urinary calculi in the 1970s, and it is still currently responsible for a significant number of calculi. In the last decade, drugs used for the treatment of HIV-infected patients, namely indinavir and sulfadiazine, have become the most frequent cause of drug-containing urinary calculi. Besides these drugs, about twenty other molecules may induce nephrolithiasis in patients receiving long-term treatment or high doses. Calculi analysis by physical methods, including infrared spectroscopy or x-ray diffraction, is needed to demonstrate the presence of the drug or its metabolites within the calculi. The second group includes drugs that provoke urinary calculi as a consequence of their metabolic effects. Here, diagnosis relies on careful clinical inquiry because physical methods are ineffective to differentiate between urinary calculi induced by the metabolic effects of a drug and common metabolic calculi. The incidence of such calculi, especially those resulting from calcium/vitamin D supplementation, is probably underestimated. Although drug-induced urinary calculi most often complicate high-dose, long-duration drug treatments, there also exist specific patient risk factors in relation to urine pH, urine output and other parameters, which provide a basis for preventive or curative treatment of calculi. Better awareness of the possible occurrence of lithogenic complications, preventive measures based on drug solubility characteristics and close surveillance of patients on long-term treatment with drugs with lithogenic potential, especially those with a history of urolithiasis, should reduce the incidence of drug-induced nephrolithiasis.
- 1 September 2002
- Vol. 12 (4) , 692-9
[Drinking water and urinary stones. Which drinking water and which modalities of diuresis?].
Urologists frequently advise a high fluid intake to their patients with calcium stones, but apart from this simple advice, they often have few convincing arguments. This article describes the various types of drinking water available in France (mineral water, spring water, tap water), the legislation concerning drinking water, and the ions that must be taken into account for long-term forced diuresis. After studying their composition and adapting the dietary advice (particularly concerning dairy foods) to this ionic composition, various types of water can be advised to patients, including tap water, most types of spring water, but not all mineral waters.
- 1 September 2002
- Vol. 12 (4) , 692-9
[Drinking water and urinary stones. Which drinking water and which modalities of diuresis?].
Urologists frequently advise a high fluid intake to their patients with calcium stones, but apart from this simple advice, they often have few convincing arguments. This article describes the various types of drinking water available in France (mineral water, spring water, tap water), the legislation concerning drinking water, and the ions that must be taken into account for long-term forced diuresis. After studying their composition and adapting the dietary advice (particularly concerning dairy foods) to this ionic composition, various types of water can be advised to patients, including tap water, most types of spring water, but not all mineral waters.
- 1 January 2002
- Vol. 26 (1) , 96-7
[Ductal adenocarcinoma of the pancreas associated with anthracosilicosis].
- 1 January 2002
- Vol. 26 (1) , 96-7
[Ductal adenocarcinoma of the pancreas associated with anthracosilicosis].